Clinical service organisation for heart failure

S Taylor1, J Bestall, S Cotter

  • 1Centre for General Practice and Primary Care, St Bartholomew's and The Royal London School of Medicine and Dentistry, Mile End Road, London, UK, E1 4NS. s.j.c.taylor@qmul.ac.uk

Insights

Disease management interventions for chronic heart failure (CHF) show potential, particularly case management, which may reduce mortality in high-quality studies. Further research is needed to confirm effectiveness and explore patient outcomes.

Area of Science:

  • Cardiology
  • Health Services Research

Background:

  • Chronic heart failure (CHF) is a prevalent condition leading to frequent hospitalizations.
  • Various clinical service organization interventions aim to manage CHF patients.

Purpose of the Study:

  • To evaluate the effectiveness of disease management interventions for patients with CHF.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) comparing CHF disease management interventions to usual care.
  • Searched multiple databases (Cochrane CENTRAL, MEDLINE, EMBASE, etc.) up to July 2003.
  • Data extraction and quality assessment performed independently by at least two reviewers.

Main Results:

  • Sixteen trials involving 1,627 patients were included, categorized into multidisciplinary, case management, and clinic interventions.
  • Case management interventions showed a trend towards reduced all-cause mortality, significant in higher-quality studies (OR 0.68, 95% CI 0.46-0.98).
  • Weak evidence suggested case management may reduce heart failure admissions; multidisciplinary interventions showed short-term reduction in heart failure re-admissions. Clinic interventions lacked strong supporting evidence.

Conclusions:

  • Current data are insufficient to make definitive recommendations for CHF disease management interventions.
  • Further adequately powered, multi-center studies are required.
  • Future research should assess intervention impact on quality of life, patient/carer satisfaction, and cost-effectiveness.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...